| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.096 | 0.07 |